Tevogen Bio - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeTevogen Bio
Tevogen Bio logo

Tevogen Bio

0 followers

TVGN

Performance

About Tevogen Bio

Tevogen Bio is a late-stage biotechnology company specializing in immunotherapy using cytotoxic T lymphocytes. Its ExacTcell platform enables scalable, off-the-shelf allogeneic CTLs for the treatment of cancers, viral infections, and prevention of long-term complications, with applications spanning oncology, neurology, and virology. The company focuses on making personalized T cell therapeutics more affordable and accessible, and is headquartered in New Jersey, United States. Tevogen also explores AI-assisted approaches through Tevogen.AI to accelerate product development while aligning pricing with broad patient access.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Ryan Saadi, MD, MPH

Chief Executive Officer

Neal Flomenberg, MD

Chief Scientific Officer and R&D Lead

Kirti Desai, CPA

Chief Financial Officer

Mittul Mehta

Chief Information Officer and Head – Tevogen AI

Sadiq Khan, MBA

Chief Commercial Officer and Interim Head of Tevogen Generics

Key Facts

HQ Location

Warren, United States

Founded

2020

Employees

11 - 50

Status

Public

Website

https://tevogen.com